APA aipamena

Sim, J., Kim, H., Hyeon, J., Choi, Y., & Han, J. (2018). Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors. J Korean Med Sci.

Chicago Style aipamena

Sim, Jongmin, Hyunjin Kim, Jiyeon Hyeon, Yoon-La Choi, and Joungho Han. "Anaplastic Lymphoma Kinase (ALK)-expressing Lung Adenocarcinoma With Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors." J Korean Med Sci 2018.

MLA aipamena

Sim, Jongmin, et al. "Anaplastic Lymphoma Kinase (ALK)-expressing Lung Adenocarcinoma With Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors." J Korean Med Sci 2018.